• Home
  • Biopharmaceutical Research Services
  • Multi-Omics Services
  • Support
  • /assets/images/icon/icon-email-2.png

    Email:

    info@MtoZ-Biolabs.com

    De Novo Sequencing in Proteomics Research

      De novo sequencing, a method widely used in proteomics research, allows for the determination of the amino acid sequence of unknown or partially known proteins. This technique is essential in scientific exploration and biomedical research because it overcomes the limitations of traditional database-dependent methods, enabling the direct derivation of protein sequences from raw mass spectrometry data. De novo sequencing is particularly useful for studying new species, phenotypic variations, or genomic deletions, providing researchers with deeper insights into protein structures and functions. This method is irreplaceable in both basic and applied research. In basic research, it helps scientists classify species, predict protein functions, and analyze protein interaction networks. In applied research, it has applications in biomarker discovery, vaccine development, synthetic biology, and identifying new drug targets. In biopharmaceuticals and diagnostics, accurate protein sequence information facilitates the development of novel therapeutic strategies and diagnostic tools. By analyzing protein sequences in detail, researchers can uncover the molecular mechanisms of diseases and propose new approaches for early diagnosis and personalized treatment. The core of de novo sequencing lies in mass spectrometry data, which provide fragment ion information of peptide segments within protein samples. By analyzing these data, complete amino acid sequences can be reconstructed. This process involves using advanced algorithms and computational models to accurately assemble sequences from fragment data, without relying on reference sequences. With ongoing advancements in computational power and algorithms, the precision and reliability of de novo sequencing have increased, making it highly effective in complex proteomics environments.

       

      The experimental workflow of de novo sequencing consists of three stages: sample preparation, mass spectrometry analysis, and data analysis. In the sample preparation stage, proteins are extracted from biological samples, and impurities are removed through purification. The proteins are then digested into peptides of appropriate lengths using specific proteases, followed by solid-phase extraction or liquid chromatography to clean the samples and ensure high-quality analysis. During mass spectrometry analysis, peptide mixtures are separated using liquid chromatography, followed by primary mass spectrometry (MS1) using high-resolution instruments (e.g., Orbitrap or Q-TOF) to measure peptide molecular weights. The peptides are then fragmented, and secondary mass spectrometry (MS/MS) data are collected to generate fragment ion spectra for sequence analysis. In the data analysis stage, specialized algorithms are applied to interpret the fragment spectra, deduce peptide sequences, identify post-translational modifications, and assemble the peptide sequences into complete protein sequences. To ensure the accuracy of the results, experimental validation or comparison with other data is performed.

       

      In practice, de novo sequencing faces challenges related to the complexity and variability of data, requiring efficient algorithms and computational power to process. Factors such as variations in fragmentation patterns, protein modifications, and sample complexity can all impact sequencing accuracy. As a result, de novo sequencing algorithms are constantly evolving, incorporating machine learning and artificial intelligence to enhance data analysis and improve accuracy.

       

      MtoZ Biolabs, a leader in proteomics, provides professional de novo sequencing services. Our experienced scientific team offers efficient and accurate protein sequence analysis, supporting both basic research and industrial applications. With advanced technology and deep academic expertise, we are equipped to handle complex samples and deliver reliable solutions. We look forward to helping research teams and enterprises achieve breakthrough discoveries and advancements through our services.

       

      MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.

      Related Services

      De Novo Sequencing Service

    Submit Inquiry
    Name *
    Email Address *
    Phone Number
    Inquiry Project
    Project Description *

     

    How to order?


    /assets/images/icon/icon-message.png

    Submit Inquiry

    /assets/images/icon/icon-return.png